Inside Innovation

Seattle-based Vedana Therapeutics emerged from stealth with $46 million in Series A financing to develop next-generation therapies for migraine prevention. The company is advancing long-acting

Adaptive Biotechnologies announced plans to pursue a separation of its Minimal Residual Disease and Immune Medicine businesses to support the growth and strategic focus of

Seattle Children’s has been awarded a grant of up to $17.25 million from Aligning Research to Impact Autism (ARIA) to join the international IMPACT Network

The University of Washington School of Medicine has received a $25 million gift from the Franke family to create the Franke Medical School Scholars Program

Bristol Myers Squibb reported phase 3 results showing that its bispecific antibody-drug conjugate izalontamab brengitecan significantly improved survival outcomes for previously treated triple-negative breast cancer

Philips plans to put its longtime Bothell campus up for sale as part of a long-term real estate strategy while maintaining its healthcare operations and

The Allen Institute has launched the Brain Health Accelerator, a new $400 million initiative aimed at developing gene therapies for neurodegenerative diseases including Alzheimer’s, Parkinson’s,

GEN’s annual ranking of the top U.S. biopharma clusters highlights the regions leading the nation in life sciences competitiveness, with Seattle ranked No. 10 overall

Aptevo Therapeutics, a Seattle-based clinical-stage biotechnology company, has received a $500,000 investment from Niowave, a Michigan-based medical radioisotopes company, as part of a collaboration to

Seattle-based AGC Biologics has been selected by Japanese pharmaceutical company Teikoku Seiyaku to provide microbial contract development and manufacturing services for KTP-001, a recombinant human

The Pacific Northwest is rapidly advancing as a center for AI-driven drug discovery through coordinated federal initiatives, startup investment, and expanding research infrastructure across Seattle,

Anthropic and the Gates Foundation have launched a four-year, $200 million partnership to support artificial intelligence initiatives focused on global health, education, and public-interest research.